Kaposi's sarcoma (KS) is a proliferative disease of vascular origin particularly frequent in HIV-1-infected homosexual men (AIDS-KS) and characterized by proliferating spindleshaped cells, angiogenesis, and inflammatory cell infiltration. Previous work has suggested that KS spindle cells are of endothelial cell origin and that chronic immune activation via the release of inflammatory cytokines may cooperate with basic fibroblast growth factor (bFGF) and the HIV-1 Tat protein in the induction and progression of AIDS-KS. Invest. 1995Invest. .95:1723Invest. -1734
Introduction
Kaposi's sarcoma (KS)' is a proliferative disease of vascular origin particularly frequent in HIV-1 infected homosexual and 1 . Abbreviations used in this paper: APAAP, alkaline phosphatase antialkaline phosphatase; bFGF, basic fibroblast growth factor; CHX, cycloheximide; CM, conditioned media; ECGS, endothelial cell growth supplement; ELAM-1, endothelial leucocyte adhesion molecule-l; FN, fibronectin; HTLV, human T cell leukemia/lymphotropic virus; HUVE, human umbilical vein endothelial; ICAM-1, intercellular cell adhesion molecule-i; KS, Kaposi's sarcoma; TBS, Tris-buffered solution; TCM, conditioned media from activated T cells; VCAM-1, vascular cell adhesion molecule-1; VN, vitronectin.
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Volume 95, April 1995, [1723] [1724] [1725] [1726] [1727] [1728] [1729] [1730] [1731] [1732] [1733] [1734] bisexual men (1) (2) (3) (4) (5) . The very early stage of KS is characterized by the presence of activated endothelial cells, angiogenesis, inflammatory cell infiltration, and by the presence of spindleshaped cells of vascular origin which, in time, become'the predominant cell phenotype (1, (6) (7) (8) (9) . These features resemble granulation tissue suggesting that KS begins as an inflammatory process mediated by cytokines (10, 11) . Inflammatory cytokines (IL-1, IL-6, tumor necrosis factor [TNF] , -y-IFN) are increased in HIV-1 -infected individuals (12) (13) (14) (15) (16) (17) (18) . Homosexuals men are subjected to a variety of sexually transmitted infections (4) and other antigenic stimuli (19) either preceding or accompanying HIV-1 infection, and often show signs of immune activation (20) (21) (22) . Consequently, they may have increased levels of inflammatory cytokines early during HIV-1 infection. Increased levels of TNFa, IL-6 and oncostatin M have been detected in skin lesions of KS (23, 24) . In addition, KS can arise prior to any T cell deficiency (25) (26) (27) . Further, the administration of TNFa or yIFN to AIDS-KS patients was reported to enhance the progression of KS (28, 29) . These findings suggested that chronic immune activation, rather than immunodeficiency, via release of inflammatory cytokines, may play a role in the induction of KS (10, 11) .
In previous studies we have shown that conditioned media (CM) from activated T cells (PBMC or enriched T cells) or human T cell leukemic/lymphotropic virus (HTLV) types I or 1I-transformed T cell lines (TCM) contain the same inflammatory cytokines found elevated in HIV-1-infected individuals (10, (14) (15) (16) (17) (18) . Also, TCM have been used to establish longterm cultures of spindle cells from KS lesions of AIDS-patients (AIDS-KS cells) (30) . When inoculated in nude mice, AIDS-KS cells induce vascular lesions of mouse cell origin closely resembling early KS in humans (KS-like lesions) (31) . These lesions are mediated by cytokines produced by AIDS-KS cells and among them, basic fibroblast growth factor (bFGF), a potent angiogenic factor (32) , appears to play a major role (33) (34) (35) . bFGF is also found expressed in spindle cells of both AIDS-KS and classical KS lesions (35, 36) and its expression and release are upregulated by inflammatory cytokines or TCM (37, 38, 38a) . Other studies indicated that KS cells proliferate in response to extracellular HIV-1 Tat protein, a viral product released by T cells during acute infection (39, 40) and found present in AIDS-KS lesions (35) . Extracellular Tat also induces the adhesion, migration and invasion of KS cells (35, 41, 42) . These effects are, at least partially, mediated by the RGD region of Tat interacting with the integrins a5f3, and a,/33, the receptors for fibronectin (FN) and vitronectin (VN) (41 ) . These integrins are upregulated during angiogenesis induced by bFGF or inflammatory cytokines (43) and are found expressed in vessels and spindle cells of AIDS-KS lesions (35) . In addition, bFGF and Tat synergize in inducing in mice lesions closely resembling early human KS (35) . All together these observations suggested that inflammatory cytokines, bFGF and Tat may cooperate in the development of KS in HIV-1-infected individuals.
It has been suggested that the spindle cells of KS are of vascular origin and probably of endothelial cell lineage (9, (44) (45) (46) (47) (48) (49) . However, cultured or in situ KS spindle cells have been reported to express only some endothelial cell markers. In addition, normal endothelial cells have a different morphology, show a proliferative response to bFGF in vitro much higher than KS spindle cells, produce little or no bFGF, do not proliferate in response to exogenous Tat protein, and do not induce KS-like lesions in mice. However, when exposed to CM from activated T cells, normal endothelial cells acquire a spindle cell morphology indistinguishable from that of KS cells (10) , produce and release bFGF (37, 38, 38a ) express higher levels of the a5/31 and a!/33 integrins (41), and become responsive to the effects of extracellular Tat ( 10, 41, 42 
Methods
Preparation of CM from activated T cells (TCM). CM were prepared from HTLV-II-infected/transformed (nonvirus producing) CD4' T cells as previously described (10, 30) . These CM contain the same inflammatory cytokines normally produced by mitogen-activated peripheral blood lymphocytes or enriched T cells from normal donors and at similar average concentration (10), but do not contain viral proteins. These include: IL-la (0.1-1 ng/ml), IL-1p ( 1-10 ng/ml), IL-2 ( < 0.1 ng/ml), IL-6 (10-40 ng/ml), TNF-a (0.1-1 ng/ml), TNF-j3 (< 100 pg/ml), granulocyte-macrophage colony stimulating factor (GM-CSF) (0.1-1 ng/ml), Oncostatin M (0.5-1 ug/ml) and y-IFN (100-200 pg/ml), as determined by ELISA Table I . Recombinant HIV-1 Tat protein from the HIV-1 1B isolate was expressed in E. coli, isolated and purified to homogeneity as previously described (40) . The procedures for maintaining biologically active Tat and preventing oxidation, and for testing its activity have been described elsewhere (40) .
Immunohistochemistry. Immunostaining was performed by both alkaline phosphatase anti-alkaline phosphatase (APAAP) method or by double indirect immunoperoxidase method using cytospin preparations of cells or cells grown for 24 h on gelatin-coated slides. Briefly, slides were fixed in cold acetone for 10', air dried, washed in Tris-buffered solution (TBS) and incubated with the primary antibody at room temperature for 20 min (APAAP method) or for 1 h (immunoperoxidase method). The slides were then rinsed in TBS and incubated at room temperature for 20 min with rabbit anti-mouse antibody (1:25, Dako, Glostrup, Denmark) or for 1 h with rabbit anti-mouse peroxidaseconjugated antibodies (1:100; Dako). The slides were washed again in TBS and the APAAP complex (1:25) or swine anti-rabbit peroxidase (1:100) were applied for an additional 20 min at room temperature. After washing in TBS, both the second and the third steps of the APAAP method were repeated to amplify the reaction. The reaction of the APAAP method was developed with the Fast Red substrate system (Dako) and the peroxidase reaction was developed with 3,3-diaminobenzidine tetrahydrochloride cromogen (Dako). Blocking of nonspecific binding and of endogenous peroxidases was performed for both methods. The percentage of positive cells in duplicate samples for each experiment and in more than five fields per slide was evaluated following counterstaining with Mayer's hematoxylin solution (Sigma Chemical Co., St. Louis, MO).
vWF detection by ELISA. HUVE and AIDS-KS cells were cultured for 6 d in the presence or in the absence of TCM as described above. Supernatants from 3 d-culture were centrifuged for 5 min at 1500 rpm and stored at -20°C until assayed.
RNA, protein, and DNA synthesis in response to bFGF or Tat. Quiescent HUVE cells were obtained by culturing cells for 24 h in the assay medium (complete medium without growth supplements, ECGS and heparin, nutridoma and with only 10% FBS) as previously described (50 cm' flask in complete medium and by culturing them for 72 h in the absence or in the presence of TCM. Cells were then trypsinized, fixed in cold 70% ethanol for 30 min in ice, centrifuged and resuspended in 500 Ail of the staining solution (100 ,ug/ml propidium iodide, 0.1% Triton X-100, 37 Atg/ml EDTA in PBS) and 500 Al of RNase (200 U/ ml). Nuclei were analyzed by flow cytometry using the Cellfit software (Becton Dickinson). 1724 Fiorelli et al. Injection of HUVE cells in nude mice before and after exposure to cytokines from activated T cells. Untreated or cytokine-treated HUVE cells (3 x 106) were injected subcutaneously into the lower back (right side) of Balb/c nu/nu athymic mice, while their negative control (media in which the cells were resuspended) were injected into the left side of the same mice, as described previously (31, 34, 35 (8, 45, 48 (10, (12) (13) (14) (15) (16) (17) (18) and they mediate endothelial cell activation (56, 57) , the same markers were analyzed in HUVE cells cultured in the absence or in the presence of TCM, which contain the same combination of inflammatory cytokines found elevated in HIV-1-infected individuals (10) (for simplicity we refer to this CM as TCM or inflammatory cytokines). As described previously (10), after treatment with TCM endothelial cells acquired a typical spindle-shaped morphology. As shown in Table I (33, (34) (35) (36) . Cultured KS cells require high levels of exogenous bFGF for growth while very low levels are needed to induce a much higher proliferative response in normal endothelial cells, such as HUVE. To verify whether inflammatory cytokines could modify the growth response of endothelial cells to bFGF, cell cycle analyses were performed with synchronized HUVE cells cultured in the absence or in the presence of TCM.
The cell transition from the quiescent to the proliferative state (GO->GI) requires an increase in the rate of RNA and protein synthesis (GI phase) necessary for cells to replicate their DNA (S phase) (64) (65) (66) (67) (68) (69) (70) . We analyzed the effect of bFGF (1 and 25 ng/ml) on RNA, protein and DNA synthesis by using synchronized HUVE cells prior to or after exposure of the cells to TCM (Fig. 2) . bFGF stimulated both treated and untreated HUVE cells to synthesize RNA and proteins with a first peak within 12 h from its addition (Fig. 2, A and B) . This allowed the cells to enter the S phase which begun at 24 h (Fig. 2  C) , completing the first synchronized cell cycle. At this time differences were observed in untreated versus cytokine-treated cells. While the kinetics of RNA, protein and DNA synthesis were similar in treated and untreated cells, cytokine-treatment induced a reduction of RNA, protein and DNA synthesis in response to bFGF (Fig. 2, A-C) . The reduction in RNA synthesis after cytokine-treatment was mostly observed between 12 h (92 and 72% reduction for 1 and 25 ng/ml bFGF, respectively [p < 0.01]) and 24 h (85 and 79% reduction for 1 and 25 ng/ ml bFGF, respectively [p < 0.01]). The reduction in protein synthesis was 86% (p < 0.01), 26 and 16% at 24, 48, and 72 h, respectively, with 1 ng/ml, while with 25 ng/ml bFGF a 53% reduction was observed at 12 h (p < 0.01). The reduction in DNA synthesis was observed at 24 h (40%), 48 h (51% [p < 0.05]) and 72 h (69% [p < 0.01]) with 1 ng/ml bFGF and at 48 h (8%) and 72 h (27%) with 25 ng/ml bFGF. By 48 and 72 h, the second phase of RNA and protein synthesis were similar in untreated and cytokine-treated cells. This is likely due to the fact that the synchronization and the assays were performed in the absence of TCM, thus, the effect of cytokine treatment, as well as the synchronization itself, declined with time. These observations suggest that the effect of inflammatory cytokines is reversible within 24 h. In addition, while with untreated HUVE cells low concentrations of bFGF (1 ng/ml) were sufficient to induce maximal DNA synthesis, higher bFGF concentrations (25 ng/ml) were required by cytokine-treated HUVE cells.
To verify whether methionine/leucine incorporation induced by bFGF corresponded to a true protein synthesis, experiments were performed in the presence or in the absence of cycloheximide (CHX), a protein synthesis inhibitor. Time points chosen for these experiments were those presenting a significant inhibition in response to bFGF after treatment with inflammatory cytokines. With untreated HUVE cells 89% inhibition (p < 0.05) and 97% (p < 0.01) were observed at 12 and 24 h, respectively; with cytokine-treated HUVE cells 71% (p < 0.05) and 86% (p < 0.01) inhibition were observed at 12 and 24 h, respectively. This indicated that the methionine/leucine incorporation induced by bFGF is due to protein synthesis.
Thus, inflammatory cytokines reduce the metabolic activities of the GI phase of the cell cycle in response to bFGF and, consequently, the S phase. To confirm this, the rate of cells in S phase was analyzed by flow cytometry using exponentially growing HUVE cells cultured for 72 h in the presence or in the absence of TCM. As shown in Fig. 3 dothelial cell growth response to bFGF and increase the concentration of the cytokine required to induce maximal cell growth.
In the presence of inflammatory cytokines Tat induces the GJ-S transition ofthe endothelial cell cycle. We have previously shown that, under standard conditions, HUVE cells do not proliferate in response to Tat and that they require a previous exposure to inflammatory cytokines to become responsive to the mitogenic effect of the protein (10, 39) . These cytokines increase the expression and the affinity of the integrins a5/31 and a,/33, which function as the receptors for Tat (41) . To analyze the effect of inflammatory cytokines on the cell growth responsiveness to Tat, cell cycle analysis was performed after addition of Tat (1 and 25 ng/ml) to untreated versus cytokineactivated and synchronized HUVE cells. In the absence of inflammatory cytokines, very low levels of RNA and protein synthesis and no DNA synthesis were observed after the addition of 1 or 25 ng/ml of exogenous Tat to the cells, suggesting that Tat may not be able to bind or to signal to untreated cells (Fig.  4, A-C, leftpanels) (41 ) . However, with cytokine-treated cells, Tat induced all the metabolic events required for cell growth. Within 3-6 h Tat stimulated RNA synthesis (Fig. 4 A, right panel [p < 0.01 or p < 0.051) and a lower increase of protein synthesis (Fig. 4 B, right panel) , while DNA synthesis was stimulated by Tat within 24 h from its addition to the cells (Fig.  4 C, right panel [p < 0.01]). As described previously (40) , Tat induced DNA synthesis in a dose-dependent fashion (Fig.  4 C, right panel) , while RNA synthesis appeared not to be dose-dependent at the concentrations tested. This is may be due to the fact that thymidine and uridine incorporation result from different processes, differently regulated during the cell cycle.
To evaluate whether the methionine/leucine incorporation induced by Tat was due to protein synthesis, experiments were performed in the presence or in the absence of CHX. As shown in Fig. 4 D, CHX inhibited Tat-induced methionine/leucine incorporation by 50% (12 h ) and 86% (24 h) in cytokinetreated HUVE cells (p < 0.01), indicating that the low levels of methionine/leucine incorporation induced by Tat result from protein synthesis.
The results indicated that Tat stimulates quiescent and cytokine-treated endothelial cells to replicate their DNA by acting on the G1 phase of the cell cycle. These results were confirmed by evaluating the effects of Tat on the distribution of cytokinetreated HUVE cells within the different phases of the cell cycle (Fig. 5 ). After addition of Tat the percentage of noncycling cells (the cells that did not go through the S phase in all the duration of the assay) was reduced by 20-30% (p < 0.01 and p < 0.05) while that with bFGF, used as control, was reduced by 36% (p < 0.01).
Cytokine-treated endothelial cells induce KS-like lesions after inoculation in nude mice. We have previously shown that injection of AIDS-KS cells into nude mice induces vascular lesions of mouse cell origin closely resembling early human KS (31, 34, 35) . These lesions which develop in response to the production of cytokines, particularly bFGF, by inoculated KS spindle cells (33) (34) (35) disappear when the proliferation of the spindle cells terminates, are not elicited by fixed cells or by normal control cells such as HUVE (31, 35) . To determine whether inflammatory cytokines induce normal endothelial cells to acquire the ability to induce KS-like lesions in nude mice, untreated or cytokine-treated cells, or the media in which they were resuspended, were injected into nude mice (Table III) . Cytokine-treated HUVE cells induced macroscopic vascular lesions in 50% of the inoculated mice while no lesions were observed after inoculation of untreated HUVE or media alone (Table III) . Furthermore, cytokine-treated cells induced histological alterations characteristic of early stage KS, and indistinguishable from those induced by cultured KS cells, in 100% of the mice inoculated (Table II and Fig. 6 ). These include angiogenesis, spindle cell growth, edema, and inflammatory cell infiltration. These results indicate that inflammatory cytokines induce normal endothelial cells to acquire angiogenic capabilities and KS-like lesion promoting activity.
Discussion
Previous studies have suggested that, at least in early stage, KS is a hyperplastic/proliferative disease of vascular origin mediated by cytokines ( 10, 1 1, 71 ). In particular, immune activation and consequent production of inflammatory cytokines (10, (12) (13) (14) (15) (16) (17) (18) may cooperate with bFGF and the HIV-1 Tat protein in the induction and progression of KS in homosexual/ bisexual men (10, 35 (Table I) . However, after culture in the absence of inflammatory cytokines, FVHI-RA and EN-4 expression reappear in low passage KS cells ( Fig. 1 and Table II) . Conversely, inflammatory cytokines induce normal endothelial cells to acquire a phenotype similar or identical to KS spindle cells including a reduction of FVIII-RA and EN-4 expression and the increase of adhesion molecules (ICAM-1, VCAM-1, and ELAM-1) to levels similar to KS cells (Table  I ). This indicates that cultured KS cells are of endothelial origin and that inflammatory cytokines regulate the expression of endothelial specific cell markers. This may also account for the variable FVIII-RA expression found in KS spindle cells in vivo (8, 9, 35, 45, 48, 60) and for the increased circulating levels of vWF found in HIV-1-infected individuals (63) .
Although bFGF acts as a growth factor for both AIDS-KS and endothelial cells (33) , a different proliferative response has been observed with these two cell types (10, 11) . Our results indicate that cytokine-treatment induces endothelial cells to acquire a growth response to bFGF similar to that observed with AIDS-KS cells (Figs. 2 and 3 ). In particular, inflammatory cytokines reduce the metabolic events induced by bFGF in the GI phase of the cell cycle (Fig. 2, A-C ) and the number of HUVE cells in S phase (Fig. 3) . In addition, they increase the concentrations of bFGF required for maximal cell growth. This may be due to a reduction in the expression of the FGF receptors by cytokines, as suggested in previous studies with IL-1 and y-IFN (72, 73) , both contained in TCM, and/or to the activation of bFGF expression by these cytokines (37, 38, 38a) .
We have previously demonstrated that Tat is a growth factor for AIDS-KS cells (39) . However, very low metabolic activities and no cell growth are induced by Tat on endothelial cells (Fig. 4, A-C, left panels) . To the contrary, after exposure to inflammatory cytokines, Tat stimulates in normal endothelial cells the metabolic events required for cell growth (Figs. 4 and 5) . Although the effect of Tat on protein synthesis is weak, Tat rapidly induced RNA synthesis, followed by DNA synthesis. The low increase in protein synthesis induced by Tat may be due to the fact that Tat induces the synthesis of specific cell cycle regulatory proteins which are undetectable by our assay, as was proposed for other systems (68, 70, 74) .
Inoculation of AIDS-KS spindle cells in nude mice induces the development of vascular lesions of mouse cell origin (31, 34, 35) which are characterized by angiogenesis, spindle cell 
